Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

26.43
+0.58002.24%
Post-market: 26.39-0.0403-0.15%19:59 EST
Volume:60.36M
Turnover:1.59B
Market Cap:150.27B
PE:15.31
High:26.65
Open:25.82
Low:25.81
Close:25.85
52wk High:27.69
52wk Low:20.92
Shares:5.69B
Float Shares:5.68B
Volume Ratio:1.37
T/O Rate:1.06%
Dividend:1.70
Dividend Rate:6.43%
EPS(TTM):1.73
EPS(LYR):1.42
ROE:10.60%
ROA:5.19%
PB:1.62
PE(LYR):18.64

Loading ...

BRIEF-Pfizer Sells Remaining Holding In BioNTech Via Block Trade, Bloomberg Reports

Reuters
·
Nov 13

BUZZ-Pfizer's India unit rises on Q2 profit jump

Reuters
·
Nov 13

HK Stock Movement | 3SBIO (01530) Surges Over 6% as Pfizer Designates 707 as Core Pipeline, Plans Multiple Clinical Studies

Stock News
·
Nov 13

Pfizer CFO to Speak at Jefferies London Healthcare Conference

Reuters
·
Nov 12

Pfizer Sept Quarter Net Profit 1.89 Billion Rupees

Reuters
·
Nov 12

Pantera Minerals Defines New Exploration Targets at Gillham Project

TIPRANKS
·
Nov 12

Cautious Optimism: Pfizer’s Strategic Initiatives and Clinical Trials Amidst Oncology Competition

TIPRANKS
·
Nov 11

Overnight Highlights Nov 11: U.S. Stocks Rise, XPeng Soars, Apple Delays Next iPhone Air, Pfizer Wins Metsera Bid

Deep News
·
Nov 11

Sector Update: Health Care Stocks Advance Monday Afternoon

MT Newswires Live
·
Nov 11

Generic Version of Pfizer's Premarin to Treat Menopausal Symptoms Receives FDA Approval

MT Newswires Live
·
Nov 11

Health Care Roundup: Market Talk

Dow Jones
·
Nov 11

Pfizer Secures Obesity Drug "Trophy" with Trump Administration's Backing

Deep News
·
Nov 11

Top Midday Stories: Over 1,400 Flights Canceled Monday and Counting; Pfizer to Acquire Metsera for up to $86.25 per Share

MT Newswires Live
·
Nov 11

FDA approves generic version of Pfizer’s Premarin

TIPRANKS
·
Nov 11

BRIEF-HHS Announces FDA Approval of Two New Drugs For Menopausal Symptoms

Reuters
·
Nov 11

Hhs: FDA, to Expand Treatment Options for Menopausal Symptoms, Is Approving a Generic Version of Premarin (Conjugated Estrogens)

THOMSON REUTERS
·
Nov 11

BRIEF-Pfizer CEO Albert Bourla Says Think Co Will Pay Entire CVR For Metsera - CNBC Interview

Reuters
·
Nov 10

Sector Update: Health Care Stocks Mixed Premarket Monday

MT Newswires Live
·
Nov 10

Pfizer Will See Big Benefits from Metsera Acquisition -- Market Talk

Dow Jones
·
Nov 10

Metsera Amends Merger Agreement with Pfizer

TIPRANKS
·
Nov 10